Importantly, these enhancements were not observed in cells co-transfected with siRNA-CDCA3 and miR-145-5p inhibitor (Fig. 7C–H), suggesting that miR-145-5p targets CDCA3 and subsequently inhibits the proliferation, migration, and invasion of HCC cells. Here, CDCA3 is linked to hepatocellular carcinoma.